Insider Transactions in Q3 2021 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
1,850
-0.97%
|
$92,500
$50.04 P/Share
|
|
Sep 24
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
3,015
-1.57%
|
$150,750
$50.11 P/Share
|
|
Sep 23
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
19,180
-4.7%
|
$959,000
$50.72 P/Share
|
|
Sep 22
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,548
-4.78%
|
$527,400
$50.09 P/Share
|
|
Sep 21
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,321
-5.69%
|
$516,050
$50.14 P/Share
|
|
Sep 17
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-5.52%
|
$36,995
$49.89 P/Share
|
|
Sep 17
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,840
-5.37%
|
$542,000
$50.05 P/Share
|
|
Sep 16
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
26,499
-1.84%
|
$1,298,451
$49.55 P/Share
|
|
Sep 15
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
54,193
-20.02%
|
$2,601,264
$48.84 P/Share
|
|
Sep 14
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
984
-0.33%
|
$49,200
$50.02 P/Share
|
|
Sep 13
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
6,660
-2.19%
|
$333,000
$50.07 P/Share
|
|
Sep 10
2021
|
Jolie Siegel Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$625,000
$50.0 P/Share
|
|
Sep 10
2021
|
Jolie Siegel Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$50,000
$4.98 P/Share
|
|
Sep 10
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
2,550
-0.81%
|
$127,500
$50.0 P/Share
|
|
Aug 20
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-5.23%
|
$30,200
$40.73 P/Share
|
|
Aug 03
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,057
-42.86%
|
$767,565
$45.01 P/Share
|
|
Aug 03
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
14,407
-13.99%
|
$648,315
$45.16 P/Share
|
|
Aug 02
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,104
-31.27%
|
$814,680
$45.0 P/Share
|
|
Aug 02
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
4,257
-3.97%
|
$191,565
$45.01 P/Share
|
|
Jul 29
2021
|
Adam Crystal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$675,000
$45.0 P/Share
|
|
Jul 29
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$60,000
$4.98 P/Share
|
|
Jul 29
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,211
-46.44%
|
$2,259,495
$45.0 P/Share
|
|
Jul 29
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
11,336
-9.56%
|
$510,120
$45.0 P/Share
|
|
Jul 29
2021
|
Jolie Siegel Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$562,500
$45.0 P/Share
|
|
Jul 29
2021
|
Jolie Siegel Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$50,000
$4.98 P/Share
|
|
Jul 16
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-4.97%
|
$27,935
$37.37 P/Share
|
|
Jul 02
2021
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
157
+50.0%
|
$6,123
$39.72 P/Share
|
|
Jul 02
2021
|
Malcolm Salter Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+2.18%
|
$13,221
$39.72 P/Share
|
|
Jul 02
2021
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
220
+0.26%
|
$8,580
$39.72 P/Share
|
|
Jul 02
2021
|
Alain J Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
251
+32.68%
|
$9,789
$39.72 P/Share
|
|
Jul 02
2021
|
Marc A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
522
+7.29%
|
$20,358
$39.72 P/Share
|
|
Jul 01
2021
|
Adam Crystal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-94.33%
|
$570,000
$38.16 P/Share
|
|
Jul 01
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.5 P/Share
|